Universitetssykehuset Nord-Norge
Tromsø, Norway
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Crohn's Disease
Eli Lilly and Company90 enrolled81 locationsNCT05509777
Recruiting
Phase 3
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Esophageal Squamous Cell Carcinoma
Karolinska University Hospital1,020 enrolled12 locationsNCT04460352